A Potential Mechanism of High-Dose Ticagrelor in Modulating Platelet Activity and Atherosclerosis Mediated by Thymic Stromal Lymphopoietin Receptor

Abnormal expression of thymic stromal lymphopoietin (TSLP) and its receptor (TSLPR) was found in patients with acute coronary syndrome. Ticagrelor, an oral platelet ADP P2Y12 receptor antagonist, is widely used in these patients. The aim of this study was to verify whether different doses of ticagre...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Yi, Peng, Yudong, Zeng, Qiutang, Cheng, Longxian, Wang, Boyuan, Mao, Xiaobo, Meng, Kai, Liu, Yuzhou, Lian, Yitian, Li, Dazhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627752/
https://www.ncbi.nlm.nih.gov/pubmed/26517374
http://dx.doi.org/10.1371/journal.pone.0141464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627752/
https://www.ncbi.nlm.nih.gov/pubmed/26517374
http://dx.doi.org/10.1371/journal.pone.0141464

Ejemplares similares